Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival Simon Maltais,

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Murat Ugur, MD, Rakesh M. Suri, MD, DPhil, Richard C

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes Erin A. Gillaspie, MD, John M. Stulak, MD, Richard C. Daly,

Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function Eduard Quintana, MD, Rakesh M. Suri,

Juan C. Araque, MD, Kevin L. Greason, MD, Zhuo Li, MS, Courtney N

Harold M. Burkhart, MD, Jeffrey B. Riley, CCP, Sarah E

Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing Jess L. Thompson, MD, Harold M. Burkhart, MD,

Superiority of cut-and-sew technique for the Cox maze procedure: Comparison with radiofrequency ablation John M. Stulak, MD, Joseph A. Dearani, MD, Thoralf.

Pulmonary hypertension in valve disease: A beast of the past?

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Go on-pump or off-pump in diabetic patients?

Quadruple valve replacement in patients with carcinoid heart disease

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

The lord of the rings Antonio Miceli, MD, PhD

Aortic valve stenosis in community medical practice: Determinants of outcome and implications for aortic valve replacement Joseph Malouf, MD, Thierry.

Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary? Nassir M.

Management of Mild Aortic Stenosis at the Time of Coronary Artery Bypass Surgery: Should the Valve Be Replaced? Basar Sareyyupoglu, MD, Thoralf M. Sundt,

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Nishant Saran, MBBS, Sameh M. Said, MD, Hartzell V

Vikas Sharma, MBBS, Rakesh M. Suri, MD, DPhil, Joseph A

Surgical ablation for atrial fibrillation for two decades: Are the results of new techniques equivalent to the Cox maze III procedure? John M. Stulak,

Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC

Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations Eduard Quintana, MD, FETCS, Pietro Bajona, MD,

Innovation and science: The future of valve design

The role of cognitive dissonance in the management of functional tricuspid regurgitation at the time of degenerative mitral valve repair Rakesh M. Suri,

It's not “just a shunt” but sometimes it should be…

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy

Niv Ad, MD, Lawrence M. Wei, MD

Replicating the success of mitral valve repair in the aortic valve

Juan G. Penaranda, MD, Kevin L. Greason, MD, Sorin V

Manuel J. Antunes, MD, PhD, DSc

John M. Stulak, MD, Rakesh M. Suri, MD, DPhil, Joseph A

Mycobacterium chimaera: The ethical duty to disclose the minimal risk of infection to exposed patients Anita Nguyen, MBBS, C. Christopher Hook, MD, Joseph.

Morgan L. Brown, MD, Hartzell V. Schaff, MD, Zhuo Li, MS, Rakesh M

Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation Morgan L. Brown,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: Establishing the benchmark against which percutaneous.

Rakesh M. Suri, MD, DPhil, Joseph A

Survival Advantage and Improved Durability of Mitral Repair for Leaflet Prolapse Subsets in the Current Era Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff,

Commentary: Three-dimensional P3 tethering angle at the heart of future surgical decision making in ischemic mitral regurgitation Wobbe Bouma, MD, PhD,

Warfarin or aspirin after mitral valve repair: Why work harder?

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

Basar Sareyyupoglu, MD, Hartzell V. Schaff, MD, Rakesh M

The future of cardiac surgery training: A survival guide

Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome Jess L. Thompson, MD, Hartzell V. Schaff,

Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices Simon.

Chan B. Park, MD, Kevin L. Greason, MD, Rakesh M. Suri, MD, Hector I

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse Rakesh M. Suri, MD, DPhil, Hartzell.

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: Should hemodynamic performance influence device selection? Rakesh.

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: Implications for revascularization in the transcatheter.

Left atrial to left ventricle bypass for mitral valve stenosis

Journal changes and initiatives

Deciding how much to pay for effective care

Presentation transcript:

Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival Simon Maltais, MD, PhD, Hartzell V. Schaff, MD, Richard C. Daly, MD, Rakesh M. Suri, MD, PhD, Joseph A. Dearani, MD, Thoralf M. Sundt, MD, Maurice Enriquez-Sarano, MD, Yan Topilsky, MD, Soon J. Park, MD, MSc The Journal of Thoracic and Cardiovascular Surgery Volume 142, Issue 5, Pages 995-1001 (November 2011) DOI: 10.1016/j.jtcvs.2011.07.044 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Overall reported 1-, 5-, and 10-year survivals for the entire cohort were 82.7%, 55.2%, and 24.3%, respectively. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 995-1001DOI: (10.1016/j.jtcvs.2011.07.044) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Survival results for propensity-matched patients. There were no differences between patients undergoing MVR or MVP. Survival was comparable between propensity-matched groups of patients (P = .72). MV, Mitral valve. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 995-1001DOI: (10.1016/j.jtcvs.2011.07.044) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions